SWM
GILD icon

Silverlake Wealth Management’s Gilead Sciences GILD Stock Holding History

Silverlake Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
2,434
-5
-0.2% -$659 0.06% 295
2026
Q1 		$340K Buy
2,439
+6
+0.2% +$840 0.07% 261
2025
Q4 		$299K Buy
2,433
+116
+5% +$14.1K 0.07% 267
2025
Q3 		$257K Sell
2,317
-201
-8% -$22.8K 0.06% 285
2025
Q2 		$279K Buy
2,518
+6
+0.2% +$639 0.08% 253
2025
Q1 		$281K Buy
2,512
+6
+0.2% +$619 0.11% 201
2024
Q4 		$231K Buy
2,506
+7
+0.3% +$630 0.09% 234
2024
Q3 		$210K Buy
+2,499
New +$191K 0.08% 254
2024
Q1 		– Sell
-2,583
Closed -$209K – 247
2023
Q4 		$209K Buy
+2,583
New +$201K 0.12% 210
2023
Q2 		– Sell
-2,906
Closed -$241K – 229
2023
Q1 		$241K Buy
2,906
+7
+0.2% +$580 0.15% 169
2022
Q4 		$249K Sell
2,899
-494
-15% -$39.1K 0.16% 167
2022
Q3 		$209K Buy
3,393
+14
+0.4% +$883 0.14% 179
2022
Q2 		$209K Buy
3,379
+14
+0.4% +$867 0.14% 181
2022
Q1 		$200K Sell
3,365
-263
-7% -$16.8K 0.11% 209
2021
Q4 		$263K Buy
+3,628
New +$250K 0.14% 169

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Silverlake Wealth Management's GILD Position: Q2 2026 in Review

Silverlake Wealth Management reduced its Gilead Sciences (GILD) stake by 0.21% in Q2 2026, selling an estimated $659 and leaving 2,434 shares worth $308K. The position accounts for 0.06% of the portfolio, ranked #295.

Silverlake Wealth Management first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. The position peaked at $340K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Silverlake Wealth Management held 2,434 shares of Gilead Sciences worth $308K as of Q2 2026.
  • Silverlake Wealth Management sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up 0.06% of Silverlake Wealth Management's portfolio in Q2 2026, its #295 holding.
  • Silverlake Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
  • Silverlake Wealth Management's Gilead Sciences position peaked at $340K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.